MLchartDataset catalogue

Fareston

Term · Oncology and biomedicine · MLC-T-ONC-003134

A drug used to treat postmenopausal women with breast cancer that has spread to other parts of the body. It is used in patients whose cancer is estrogen receptor positive (ER+) or when it is not known if the cancer is ER+ or estrogen receptor negative (ER-). Fareston blocks the effects of the hormone estrogen in breast tissue, which may help keep breast cancer cells from growing. It is a type of selective estrogen receptor modulator (SERM). Also called toremifene citrate.

Table 1. Record
IdentifierMLC-T-ONC-003134
FieldOncology and biomedicine
Synonymstoremifene citrate
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003134",
  "term": "Fareston",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat postmenopausal women with breast cancer that has spread to other parts of the body. It is used in patients whose cancer is estrogen receptor positive (ER+) or when it is not known if the cancer is ER+ or estrogen receptor negative (ER-). Fareston blocks the effects of the hormone estrogen in breast tissue, which may help keep breast cancer cells from growing. It is a type of selective estrogen receptor modulator (SERM). Also called toremifene citrate.",
  "synonyms": [
    "toremifene citrate"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/fareston/"
}

Record 7,154 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.